189 related articles for article (PubMed ID: 16181427)
1. TAT-mediated endocytotic delivery of the loop deletion Bcl-2 protein protects neurons against cell death.
Soane L; Fiskum G
J Neurochem; 2005 Oct; 95(1):230-43. PubMed ID: 16181427
[TBL] [Abstract][Full Text] [Related]
2. Limited protection of TAT-Bcl-X(L) against pneumolysin-induced neuronal cell death.
Ebert S; Dietz GP; Mitchell TJ; Michel U; Bähr M; Nau R
Neurosci Lett; 2005 Aug; 384(3):349-53. PubMed ID: 15961228
[TBL] [Abstract][Full Text] [Related]
3. Protection against ischemic brain injury by protein therapeutics.
Asoh S; Ohsawa I; Mori T; Katsura K; Hiraide T; Katayama Y; Kimura M; Ozaki D; Yamagata K; Ohta S
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17107-12. PubMed ID: 12475933
[TBL] [Abstract][Full Text] [Related]
4. Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice.
Kilic E; Dietz GP; Hermann DM; Bähr M
Ann Neurol; 2002 Nov; 52(5):617-22. PubMed ID: 12402259
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets.
Klein D; Ribeiro MM; Mendoza V; Jayaraman S; Kenyon NS; Pileggi A; Molano RD; Inverardi L; Ricordi C; Pastori RL
Biochem Biophys Res Commun; 2004 Oct; 323(2):473-8. PubMed ID: 15369775
[TBL] [Abstract][Full Text] [Related]
6. A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo.
Kashio A; Sakamoto T; Suzukawa K; Asoh S; Ohta S; Yamasoba T
J Neurosci Res; 2007 May; 85(7):1403-12. PubMed ID: 17387707
[TBL] [Abstract][Full Text] [Related]
7. Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity.
Sengoku T; Bondada V; Hassane D; Dubal S; Geddes JW
Exp Neurol; 2004 Jul; 188(1):161-70. PubMed ID: 15191812
[TBL] [Abstract][Full Text] [Related]
8. Protection of hippocampal neurogenesis by TAT-Bcl-x(L) after cerebral ischemia in mice.
Doeppner TR; Dietz GP; Weise J; Bähr M
Exp Neurol; 2010 Jun; 223(2):548-56. PubMed ID: 20156439
[TBL] [Abstract][Full Text] [Related]
9. HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis.
Diem R; Taheri N; Dietz GP; Kuhnert A; Maier K; Sättler MB; Gadjanski I; Merkler D; Bähr M
Neurobiol Dis; 2005 Nov; 20(2):218-26. PubMed ID: 16242630
[TBL] [Abstract][Full Text] [Related]
10. Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis.
Wang Q; Gou X; Xiong L; Jin W; Chen S; Hou L; Xu L
Anesthesiology; 2008 Jun; 108(6):1071-80. PubMed ID: 18497608
[TBL] [Abstract][Full Text] [Related]
11. CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway.
Chun H; Hao W; Honghai Z; Ning L; Yasong W; Chen D
Brain Res; 2009 Feb; 1257():75-88. PubMed ID: 19100722
[TBL] [Abstract][Full Text] [Related]
12. Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain.
Lee KO; Luu N; Kaneski CR; Schiffmann R; Brady RO; Murray GJ
Biochem Biophys Res Commun; 2005 Nov; 337(2):701-7. PubMed ID: 16223608
[TBL] [Abstract][Full Text] [Related]
13. TAT-Bcl-x(L) improves survival of neuronal precursor cells in the lesioned striatum after focal cerebral ischemia.
Doeppner TR; Dietz GP; El Aanbouri M; Gerber J; Witte OW; Bähr M; Weise J
Neurobiol Dis; 2009 Apr; 34(1):87-94. PubMed ID: 19167500
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction.
Dietz GP; Kilic E; Bähr M
Mol Cell Neurosci; 2002 Sep; 21(1):29-37. PubMed ID: 12359149
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.
Cao G; Pei W; Ge H; Liang Q; Luo Y; Sharp FR; Lu A; Ran R; Graham SH; Chen J
J Neurosci; 2002 Jul; 22(13):5423-31. PubMed ID: 12097494
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of TAT PTD-Ngb fusion protein on primary cortical neurons against hypoxia-induced apoptosis.
Zhou G; Shan P; Hu X; Zheng X; Zhou S
Neurol Sci; 2013 Oct; 34(10):1771-8. PubMed ID: 23456442
[TBL] [Abstract][Full Text] [Related]
17. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.
Nagel F; Falkenburger BH; Tönges L; Kowsky S; Pöppelmeyer C; Schulz JB; Bähr M; Dietz GP
J Neurochem; 2008 May; 105(3):853-64. PubMed ID: 18182047
[TBL] [Abstract][Full Text] [Related]
18. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice.
Toro A; Grunebaum E
J Clin Invest; 2006 Oct; 116(10):2717-26. PubMed ID: 16964310
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences.
Wei Xu ; Miou Zhou ; Baudry M
Neuroscientist; 2008 Oct; 14(5):409-14. PubMed ID: 18000067
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy for introducing exogenous bcl-2 into neuronal cells: the Cre/loxP system-mediated activation of bcl-2 for preventing programmed cell death using recombinant adenoviruses.
Sato N; Wang S; Li L; Okabe K; Hashimoto M; Yaginuma H; Mikoshiba K; Uchiyama Y; Uetsuki T; Yoshikawa K; Milligan CE; Oppenheim RW
Mol Cell Neurosci; 1998 Sep; 12(1-2):65-78. PubMed ID: 9770341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
